Leukemia inhibitory factor and oncostatin M influence the mineral phases formed in a murine heterotopic calcification model: A fourier transform- infrared microspectroscopic study

Journal of Bone and Mineral Research

Volumn 13, Issue 10, 1998, Pages 1619-1632

  Bohic, S ^a   Rohanizadeh, R ^a   Touchais, S ^b   Godard, A ^c   Daculsi, G ^a   Heymann, D ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW CELL; BONE MINERALIZATION; CALCIFICATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; INFRARED SPECTROSCOPY; INHIBITION KINETICS; LEUKEMIA; MOUSE; NONHUMAN;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CALCINOSIS; CELLS, CULTURED; FEMALE; GROWTH INHIBITORS; INTERLEUKIN-6; KIDNEY; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MICE; MICROCHEMISTRY; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; MINERALS; NEPHROCALCINOSIS; ONCOSTATIN M; PEPTIDES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRANSPLANTATION, HETEROTOPIC;

EID: 0031694942     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.10.1619     Document Type: Article

References (55)

1. Godard A, Gascan H, Naulet J, Peyrat MA, Jacques Y 1988 Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 71:4618-1623.
2. Anegon I, Moreau JF, Godard A, Hallet MM, Wong G, Jacques Y, Peyrat MA, Soulillou JP 1990 Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol 130:50-65.
3. Gascan H, Anegon I, Praloran V, Naulet J, Godard A, Soulillou JP, Jacques Y 1990 Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol 144:2592-2598.
4. Malik N, Kallestad JC, Gunderson NL, Austin SC, Neubauer MG, Och V, Marquardt H, Zarling JM, Shobay M, Wei CM, Linsley PS, Rose TM 1989 Molecular cloning, sequence analysis and functional expression of a novel growth regulator: Oncostatin M. Mol Cell Biol 9:2847-2853.
5. Brown TJ, Lioubin MN, Marquardt H 1987 Purification and characterization of cytostatic lymphocytes produced by activated human T-lymphocytes: Synergistic antiproliferative activity of transforming growth factor β1, interferon γ and oncostatin M for human melanoma cells. J Immunol 139: 2977-2983.
6. Rose TM, Bruce AG 1991 Oncostatin M is a member of a cytokine family that includes leukemia inhibitory factor, granulocyte colony-stimulating factor and interleukin 6. Proc Natl Acad Sci USA 88:8641-8645.
7. Nicola NA, Cross B, Simpson RJ 1993 The disulfide bond arrangement of leukemia inhibitory factor: Homology to oncostin M and structural implications. Biochem Biophys Res Commun 190:20-26.
8. Sutherland GR, Baker E, Hyland VJ, Callen DF, Stahl J, Gough NM 1989 The gene human leukemia inhibitory factor (LIF) maps to 22q 12. Leukemia 3:9-13.
9. Giovannini M, Selleri L, Hermason GG, Evans GA 1993 Localization of the human oncostatin M gene (OSM) to chromosome 22q12, distal to the Ewing's sarcoma breakpoint. Cytogenet Cell Genet 62:32-34.
10. Piquet-Oellorce C, Grey L, Mereau A, Heath JK 1994 Are LIF and related cytokines functionally equivalent? Exp Cell Res 213:340-347.
11. Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK 1994 Oncostatin M and Leukemia Inhibitory Factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 269:6215-6222.
12. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Mosley B, Ziegler SF, Cosman D 1992 The IL-6 signal transducer, gp130: An Oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437.
13. Gearing DP, Bruce AG 1992 Oncostatin M binds the high-affinity Leukemia Inhibitory Factor receptor. New Biol 4:61-65.
14. Metcalf D, Gearing DP 1989 Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 86:5948-5952.
15. Bellido T, Stahl N, Farruggella TJ, Borda V, Yancopoulos GD, Manolagas SC 1996 Detection of receptors for interleukin-6, leukemia inhibitory factor, oncosatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 97:431-437.
16. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble interleukin-6 receptors trigger osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 90:11924-11928.
17. Lowe C, Cornish J, Martin TJ, Reid IR 1991 Effects of leukemia inhibitory factor on bone resorption and DNA synthesis in neonatal calvaria. Calcif Tissue Int 49:394-397.
18. Reid IR, Lowe C, Cornish J, Skinner SJM, Hilton DJ, Willson TA, Gearing DP, Martin TJ 1990 Leukemia inhibitory factor: A novel-bone active cytokine. Endocrinology 126:1416-1420.
19. Van Beek E, van der Wee-Pals L, van de Ruit M, Nijweide P, Papapoulos S, Lowik C 1993 Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal hones in culture. J Bone Miner Res 8:191-197.
20. Noda M, Vogel RL, Hasson DM, Rodan GA 1990 Leukemia inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger ribonucleic acid level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3-E1) cells. Endocrinology 127:185-190.
21. Jay PR, Centrella M, Lorenzo J, Bruce AG, Horowitz MC 1996 Oncostatin-M: A new bone active cytokine that activates osteoblasts and inhibits bone resorption. Endocrinology 137: 1151-1158.
22. Drize NJ, Gan OI, Chertkov JL, Godard A, Jacques Y 1996 The effect of Leukemia Inhibitory Factor (LIF) on hematopoietic and stromal precursor cells in murine long-term bone marrow culture. Bull Eksp Biol Med 122:325-338.
23. Godard A, Heymann D, Raher S, Anegon I, Peyrat MA, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou JP, Moreau JF, Jacques Y 1992 High and low affinity receptors for human interleukin for DA cells/Leukemia inhibitory factor on human cells: Molecular characterization and cellular distribution. J Biol Chem 267:3214-3220.
24. Friedenstein AJ, Petrakova KV, Kurolesova AJ, Frolova GP 1968 Heterotopic transplants of bone marrow: Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247.
25. Gadaleta SJ, Camacho NP, Mendelsohn R, Boskey AL 1996 Fourier transform infrared microscopy of calcified turkey leg tendon. Calcif Tissue Int 58:17-23.
26. Paschalis EP, Jacenko O, Olsen B, Mendelsohn R, Boskey AL 1996 Fourier transform infrared microspectroscopic analysis identifies alterations in mineral properties in bones from mice transgenic for type X collagen. Bone 19:151-156.
27. Paschalis EP, Betts F, DiCarlo E, Mendelsohn R, Boskey AL 1997 FTIR microspectroscopic analysis of normal human cortical and trabccular bone. Calcif Tissue Int 61:480-486.
28. Pleshko NL, Boskey AL, Mendelsohn R 1992 An infrared study of the interaction of polymethyl methacrylate with the protein and mineral components of bone. J Histochem Cytochem 40:1413-1417.
29. Boskey AL, Pleshko N, Doty SB, Mendelsohn R 1992 Applications of Fourier Transform Infrared (FT-IR) microscopy of mineralization in bone and cartilage. Cells Mater 2:209-219.
30. Paschalis EP, DiCarlo E, Betts F, Sherman P, Mendelsohn R, Boskey AL 1996 FTIR microspectroscopic analysis of human osteonal bone. Calcif Tissue Int 59:480-487.
31. Kauppinen JK, Moffatt DJ, Mantsh HH, Cameron DG 1981 Fourier self-deconvolution: A method for resolving intrinsically overlapped bands. Appl Spectrosc 35:271-276.
32. Surewicz WK, Mantsh HH 1988 New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochem Biophys Acta 952:115-130.
33. Heymann D, Touchais S, Bohic S, Rohanizadeh R, Coquard C, Passuti N, Daculsi G 1998 Heterotopic implantation of mouse bone-marrow cells: An in vivo model allowing analysis of mineral phases during mineralization processes. Connect Tissue Int (in press).
34. Maddams WF, Mead WL 1982 The measurement of derivative IR specta-I. Background studies. Spectrochim Acta 38A:437-444.
35. Heymann D, Guicheux J, Gouin F, Passuti N, Daculsi G 1997 Cytokines, growth factors and osteoclasts. Cytokine 10:155-168.
36. Alsina M, Guise TA, Roodman GD 1996 Cytokine regulation of bone cell differentiation. Vitam Horm 52:63-98.
37. Boskey AL 1996 Matrix proteins and mineralization: An overview. Connect Tissue Res 35:357-363.
38. Robey PG, Boskey AL 1996 The biochemistry of bone. In: Marcus R, Feldman D, Kelsey J (eds.) Osteoporosis, Chp. 4. Academic Press, New York, U.S.A., pp. 95-183.
39. Mundy GR 1993 Cytokines and growth factors in the regulation of bone remodeling. J Bone Miner Res 8:S505-S510.
40. LeGeros RZ 1991 Calcium phosphates in oral biology and medicine. In: Monographs in Oral Sciences. Myers HM (ed.) Karger, New York, U.S.A.
41. Daculsi G, Bouler JM, LeGeros RZ 1997 Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials. Int Rev Cytol 172:129-191.
42. Bigi A, Foresti E, Gregorini R, Ripamonti A, Roveri N, Shah JS 1992 The role of magnesium on the structure of biological apatites. Calcif Tissue Int 50:439-444.
43. LeGeros RZ, Contiguglia SR, Alfrey AC 1973 Pathological calcifications associated with uremia: Two types of calcium phosphate deposits. Calcif Tissue Res 13:173-185.
44. Levy JB, Schindler C, Raz R, Levy DE, Baron R, Horowitz MC 1996 Activation of the JAK-STAT signal transduction pathway by oncostatin-M in cultured human and mouse osteoblastic cells. Endocrinology 137:1159-1165.
45. Lowe C, Gillespie GAJ, Pike JW 1995 Leukemia inhibitory factor as a mediator of JAK/STAT activation in murine osteoblasts. J Bone Miner Res 10:1644-1650.
46. Takahashi K, Manolagas SC, Jilka RL 1995 Leukemia inhibitory factor (LIF) stimulates osteoblasto-genesis from undifferentiated mesenchymal progenitors of the bone marrow. J Bone Miner Res 10(Suppl. 1):S317.
47. 4 domain. Calcif Tissue Int 49:383-388.
48. Camacho NP, Landis WJ, Boskey AL 1996 Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier Transform Infrared microscopy. Connect Tissue Res 35:259-265.
49. Markovic M, Takagi S, Chow LC 1996 Calcium phosphate cements with incorporated carbonate ions. J Dent Res 75:25 (abstract 59).
50. LeGeros RZ 1981 Apatites in biological systems. Prog Crystal Growth Charact 4:1-45.
51. Bigi A, Foresti E, Incerti A, Roveri N, Borea PA, Zavagli G 1980 Chemical and structural study of the mineral phase associated with a human subcutaneous ectopic calcification. Inorg Chim Acta 46:271-274.
52. LeGeros RZ, Kijkwoska R, Bautista C, LeGeros JP 1995 Synergistic effects of magnesium on carbonate and properties of biological and synthetic apatites. Connect Tissue Res 33:203-209.
53. Gadaleta SJ, Paschalis EP, Betts F, Mendelsohn R, Boskey AL 1996 Fourier transform infrared spectroscopy of the solution mediated conversion of amorphous calcium phosphate to hydroxyapatite: New correlation between x-ray diffraction and infrared data. Calcif Tissue Int 58:9-16.
54. Rey C, Kim HM, Gerstenfeld L, Glimcher MJ 1995 Structural and chemical characteristics and maturation of the calcium-phosphate crystal formed during the calcification of the organic matrix synthetized by chicken osteoblasts in cell culture. J Bone Miner Res 10:1577-1588.
55. Rey C, Renugopalakrishnan V, Collins B, Glimcher MJ 1991 Fourier Transform Infrared spectroscopy study of the carbonate ions in bone mineral during aging. Calcif Tissue Int 149: 251-258.